Page last updated: 2024-12-08

dihydrochandonium iodide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dihydrochandonium: RN given refers to di-iodide; RGH-4201 refers to di-bromide salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID171739
MeSH IDM0075699

Synonyms (13)

Synonym
naphtho(2,1-f)quinolinium, octadecahydro-1,1,10a,12a-tetramethyl-8-(1-methylpyrrolidinio)-, diiodide, (4as,4br,6as,8s,10as,10bs,12as)-
dihydrochandonium dibromide
17a-methyl-3beta-pyrrolidino-17a-aza-d-homo-5alpha-androstane dimethiodide
(3beta,5alpha)-17a,17a-dimethyl-3-(1-methylpyrrolidinio)-17a-azonia-d-homoandrostane, diiodide
naphtho(2,1-f)quinolinium, octadecahydro-1,1,10a,12a-tetramethyl-8-(1-methylpyrrolidinio)-, diiodide, (4as-(4aalpha,4bbeta,6aalpha,8beta,10abeta,10balpha,12abeta))-
66052-67-3
dihydrochandonium iodide
hs 692
17a-azonia-d-homoandrostane, (17a,17a-dimethyl-3-(1-methylpyrrolidinio)-, diiodide, (3beta,5alpha)-
dihydrochandonium diiodide
dihydrochandonium
DTXSID90984522
(4as,4br,6as,8s,10as,10bs,12as)-1,1,10a,12a-tetramethyl-8-(1-methylpyrrolidin-1-ium-1-yl)-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydro-2h-naphtho[2,1-f]quinolin-1-ium;diiodide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.94 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (14.29%)4.05%
Observational0 (0.00%)0.25%
Other5 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]